Samsung Biologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	148,851	391,222	367,937	890,820	47,410
Short-Term Investments	1,336,232	940,067	1,688,338	2,204,212	473,985
Trading Asset Securities	-	-	-	98,506	850,040
Cash & Short-Term Investments	1,485,083	1,331,289	2,056,276	3,193,537	1,371,435
Cash Growth	11.55%	-35.26%	-35.61%	132.86%	60.96%
Accounts Receivable	654,728	-0	-	-	0
Other Receivables	21,739	-	-	-	-
Receivables	676,467	-0	-	-	0
Inventory	2,128,164	2,818,276	2,641,368	2,375,819	1,012,871
Prepaid Expenses	14,349	28,251	26,830	23,201	8,579
Other Current Assets	104,304	1,340,302	797,513	865,099	430,291
Total Current Assets	4,408,367	5,518,118	5,521,988	6,457,657	2,823,175
Property, Plant & Equipment	6,037,532	5,837,482	4,342,424	3,871,452	2,227,687
Long-Term Investments	78,325	59,605	47,435	38,110	2,661,499
Goodwill	-	1,677,608	1,677,608	1,677,608	-
Other Intangible Assets	60,193	1,294,705	1,580,423	1,541,850	32,172
Long-Term Accounts Receivable	-	0	0	-0	0
Long-Term Deferred Tax Assets	132,837	165.09	-	-	-
Long-Term Deferred Charges	-	2,592,990	2,574,057	2,741,848	-
Other Long-Term Assets	343,458	355,592	302,236	253,524	225,477
Total Assets	11,060,742	17,336,296	16,046,197	16,582,050	7,970,011
Accounts Payable	59,814	177,992	201,709	59,616	32,251
Accrued Expenses	314,573	545,403	281,317	207,437	74,322
Short-Term Debt	-	327,000	654,500	582,783	50,000
Current Portion of Long-Term Debt	319,713	-	733,405	556,017	109,855
Current Portion of Leases	7,258	138,594	144,031	142,247	7,537
Current Income Taxes Payable	355,700	375,388	191,212	223,299	110,174
Current Unearned Revenue	-	400,007	399,818	432,680	-
Other Current Liabilities	1,475,860	1,888,804	1,551,870	1,977,462	723,156
Total Current Liabilities	2,532,917	3,853,188	4,157,861	4,181,542	1,107,295
Long-Term Debt	599,012	1,012,757	239,783	965,090	1,114,684
Long-Term Leases	1,112	7,889	137,614	267,896	10,671
Pension & Post-Retirement Benefits	-	5,547	5,117	-	-
Long-Term Deferred Tax Liabilities	-	972,062	1,184,420	1,214,216	487,712
Other Long-Term Liabilities	476,590	580,177	490,910	968,833	258,547
Total Liabilities	3,609,631	6,431,620	6,215,705	7,597,576	2,978,909
Common Stock	115,727	177,935	177,935	177,935	165,413
Additional Paid-In Capital	3,391,926	5,663,111	5,663,111	5,663,111	2,487,313
Retained Earnings	6,870,961	5,086,609	4,003,293	3,145,601	2,347,187
Treasury Stock	-2,907,695	-	-	-	-
Comprehensive Income & Other	-19,809	-22,979	-13,847	-2,173	-8,811
Shareholders' Equity	7,451,111	10,904,676	9,830,492	8,984,474	4,991,102
Total Liabilities & Equity	11,060,742	17,336,296	16,046,197	16,582,050	7,970,011
Total Debt	927,094	1,486,239	1,909,333	2,514,033	1,292,747
Net Cash (Debt)	557,989	-154,951	146,943	679,504	78,688
Net Cash Growth	-	-	-78.38%	763.54%	17.19%
Net Cash Per Share	8326.90	-2177.12	3174.34	14965.87	1828.54
Filing Date Shares Outstanding	129.17	46.29	46.29	46.29	43.03
Total Common Shares Outstanding	129.17	46.29	46.29	46.29	43.03
Working Capital	1,875,449	1,664,929	1,364,127	2,276,115	1,715,881
Book Value Per Share	57685.15	235568.21	212363.16	194087.06	115982.76
Tangible Book Value	7,390,917	7,932,363	6,572,461	5,765,016	4,958,931
Tangible Book Value Per Share	57219.14	171358.83	141981.56	124538.73	115235.15
Land	461,974	141,114	141,065	141,065	-
Buildings	3,337,895	1,956,958	1,943,694	1,376,222	832,519
Machinery	3,262,177	2,629,598	2,525,344	1,811,982	1,380,919
Construction In Progress	430,161	1,833,097	202,411	825,199	583,360

Source: S&P Global Market Intelligence. Standard template. Financial Sources.